California lawmakers are weighing a bill that would cut off most drugmaker payments to physicians, including speaking fees for that staple of pharma marketing…

Soap operas often include medical mysteries and miracles, but some doctors are concerned about Incyte's connection to General Hospital's latest drama.

Last year, the FDA nixed Vertex’s bid to expand Kalydeco to patients with specific mutations in the CFTR gene. On Wednesday, though, the drugmaker finally got…

The FDA has approved an immuno-oncology med as a new treatment for bladder cancer—for the third week in a row. Only this one has positive overall survival data…

No company playing from behind in a competitive market wants to land a serious new safety warning. But that’s exactly the position Johnson & Johnson is in…

An ad campaign sponsored by Avanir featuring neurological condition PBA has helped fuel the controversy over how DTC advertising fosters the use of pricey meds.

Pfizer new Antimicrobial Testing Leadership and Surveillance, or ATLAS, system offers global antibiotic resistance data with user-friendly website along with a…

It's déjà vu in the pharma TV ad spending world. April's top spenders were almost a repeat from the previous month, with four of the five top brands…

Marketing